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Abstract 
Upper urinary tract urothelial carcinoma exhibiting variant morphology, especially in higher-
grade tumors, is a recognized phenomenon but has not been comparatively studied in biopsy 
versus resection material. We studied the morphologic patterns and clinicopathological 
features, and provide a comparison between biopsy and resection specimens. Consultation 
cases were evaluated separately to investigate for possible consultation bias. A total of 383 in-
house cases from 352 patients including 314 resection specimens and 69 biopsies from 2001-
2014 were reviewed from a single institution. Histologic type, tumor grade, invasion, 
pathologic stage, nodal status, metastasis, and the presence and type of variant morphology 
for each case were evaluated. Variant morphology was identified in 5 biopsy specimens 
(7.2%) and 42 resection specimens (13.4%). The most common variant morphologic pattern 
was squamous differentiation (16 cases, 4.5%) followed by an inverted growth pattern (8 
cases, 2.2%). The presence of variant morphology in resection specimens had a significant 
association with higher tumor grade, higher pT stage, and non-papillary configuration. Out of 
69 patients with biopsies, 31 had a subsequent resection. In comparison, 181 consultation 
cases from 168 patients showed variant morphology in six biopsies (7.1%) and twenty-seven 
resections (28.1%). In conclusion, the frequency of recognizing variant morphology in 
biopsies is about one-half of that in resections. The inclusion of consultation cases can inflate 
the incidence of variant morphology. As a result, the frequency of variant morphology in our 
in-house cases is lower than the percentage reported in the literature, most likely secondary to 
a consultation bias.  
Keywords: Upper urinary tract, urothelial carcinoma; variant 
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1. 1  
Introduction 
Urothelial neoplasms of upper urinary tract are uncommon, accounting for 
approximately 5% of all epithelial tumors of the urinary tract [1]. Eighty percent of those are 
malignant, with urothelial carcinoma (UC) accounting for 90%. From 2004–2010, the 
percentage of in situ cases increased while stage IV cases have decreased [2]. Upper urinary 
tract urothelial carcinoma (UTUC) exhibiting variant morphology is a well-recognized 
phenomenon, and has been reported to be associated with a higher grade, higher stage, higher 
frequency of lymphovascular invasion, and increased recurrence [3-7].  
Recognition of variant morphology is not only essential for management decisions but 
also necessary to rule out metastasis or secondary involvement from adjacent malignancies 
[8]. The reported frequency of UTUC variant morphology in surgical resections; i.e., 
nephroureterectomy or ureterectomy, has ranged from 12–40% in the larger published series 
[4-7]. However, the frequency of variant morphology in biopsies and their subsequent 
resection specimens has not been previously reported. We analyzed a large volume of cases 
from a single institution, comparing findings from both in-house and consultation cases, in 
order to investigate the true incidence of variant morphology in UTUC and determine the 
presence and significance of the consultation bias. 
1.2  
Materials and Methods 
 An electronic data search was performed from our institutional files from January 
2001 through December 2014 to include all biopsies and surgical resections with a final 
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diagnosis of UTUC. Included cases of UTUC were from nephrectomies, 
nephroureterectomies, and ureterectomies, as well as all biopsies from the portion of the 
urinary tract above the urinary bladder (renal pelvis and ureter). The cases were separated 
based on service type: in-house or consultation. In-house cases included all biopsy and 
resection procedures performed at the hospital sites within our institution and directly served 
by our department. Consultation cases were cases sent to our department from other 
institutions for expert interpretation.  
All case documentation was analyzed and the diagnoses were confirmed by reviewing 
the corresponding hematoxylin and eosin–stained sections. The clinical information of each 
patient was reviewed from all available electronic medical records, and the following data 
points were recorded: (1) age at time of diagnosis, (2) gender, (3) stage, (4) development of 
recurrence and/or metastasis, and (5) status of disease at last follow-up.  
These UTUC cases were reviewed for various histologic features, including configuration, 
grade of tumor, pathologic stage, vascular invasion, and the presence and type of variant 
morphology. The configuration was classified as papillary or non-papillary based on the 
architecture. Tumors were classified as low grade or high grade according to criteria set by 
the World Health Organization (WHO)/International Society of Urological Pathology (ISUP) 
grading system [9]. Tumor staging was performed according to the 2010 American Joint 
Committee on Cancer TNM staging system [10]. We defined low pT to be pTa, pTis, and 
pT1. Cases with a pT of pT2 or higher were designated as high pT for our analysis. Variant 
morphology was classified using the WHO 2016 classification and additional recently 
reported patterns in literature [8, 9, 11-13].   
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Statistical analysis between cases with and without variant morphology and for 
clinicopathologic factors was performed using the chi-square test or the Fisher exact test. For 
all data reported, results with a p value <0.05 were considered statistically significant. All 
data was analyzed using EZR (Saitama Medical Center, Jichi Medical University), which is a 
graphical user interface for R (The R Foundation for Statistical Computing, version 3.1.2) 
[14]. 
In concordance with our institutional policy, all patients seen within our hospital 
system have given consent for materials to be used for research purposes in an anonymous 
fashion. Furthermore, this study is granted exemption status by our Institutional Review 
Board. 
1.3  
Results 
Over the fourteen-year study period, a total of 383 in-house cases from 352 patients 
were identified. These included 69 biopsies and 314 resections (202 nephroureterectomies, 
112 ureterectomies). The clinicopathological characteristics associated with variant 
morphology in biopsies and resections from in-house cases are provided in Table 1. The 
patients ranged in age from 37-95 years (mean 70.6 years); the male to female ratio was 
1.6:1. The follow-up time ranged from 1–139 months (median, 8 months). The most common 
architecture was papillary, followed by infiltrative/nodular (Figure 1A, B). Overall, 46 cases 
(13%) showed the presence of variant morphology, of which 44 cases (95.6%) were high-
grade, and 39 cases (84.7%) were invasive. The presence of variant morphology had a 
significant correlation with non-papillary configuration (P=0.013), high grade (P=0.0127), 
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and high pT stage (P=0.0002) (Table 2). 
During the same time period, a total of 181 consultation cases from 168 patients were 
identified. These included 85 biopsies and 96 resections (77 nephroureterectomies, 19 
ureterectomies). Clinical information provided with consultation cases was often limited to 
age, sex, and operative procedure. The patients ranged in age from 14-87 years (mean 64.2 
years); the male to female ratio was 1.1:1. The follow-up time was not available. The most 
common architecture was papillary. Overall, 33 cases (18%) showed the presence of variant 
morphology, of which 44 cases (87.9%) were of high-grade morphology. 
1.3.1 
Biopsies: 
 A total of 69 in-house biopsies from the upper urinary tract with a diagnosis of 
urothelial carcinoma were identified. Of these, 31 cases had subsequent resections. Patient 
age ranged from 52-80 years (mean 69.9 years), and the male to female ratio was 3:2. Five 
cases (7.3%) showed the presence of variant morphology and four of these cases (80.0%) 
were high-grade tumors. Three of these 5 cases (60.0%) showed invasion. Variant 
morphology in biopsy specimens showed no significant correlation with configuration 
(P=0.241), grade (P=0.643), or higher pT stage (P=0.211) (Tables 2 and 3).  
 A total of 85 consultation biopsies diagnosed as UTUC were identified. Of these, 13 
cases included subsequent resections. Patient age ranged from 14-87 years (mean 68.4 years), 
and the male to female ratio was 1.5:1. Six cases (7.1%) showed the presence of variant 
morphology and five of these cases (83.3%) were high-grade tumors. 
1.3.2 
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Resections:  
For the 314 in-house resection cases, the patient age ranged from 37-95 years (mean- 
70.6 years), and the male to female ratio was 2:1. Forty-two cases (13.4%) displayed variant 
morphology, 40 (95.2%) of which occurred in high-grade tumors, and 36 (85.7%) in invasive 
carcinomas. Unlike in the biopsy group, the presence of variant morphology had a significant 
correlation with non-papillary configuration (P=0.013), high grade (P=0.0127), and high pT 
stage (P=0.0002) (Tables 2 and 4). 
For the 96 consultation resection cases, the patient age ranged from 21-87 years 
(mean 66.0 years), and the male to female ratio was 0.96:1. Twenty-seven cases (28.1%) 
displayed variant morphology, 24 (88.9%) of which occurred in high-grade tumors. 
1.3.3 
Variant morphologic patterns: 
Of 352 in-house patients, 306 were cases of usual urothelial carcinoma and the 
remaining 46 patients displayed variant morphology. Squamous differentiation (16 cases, 
4.1%) was the most common, followed by inverted growth pattern (8 cases, 2.5%), 
sarcomatoid (7 cases, 1.8%), glandular differentiation (6 cases, 1.6%), and micropapillary (4 
cases, 0.9%) (Table 5; Figure 1). Other less common patterns included plasmacytoid (2 cases, 
0.6%), giant cell (1 case, 0.3%), and lymphoepithelioma-like (1 case, 0.3%) (Figure 2). Two 
cases with squamous differentiation also had sarcomatoid and glandular differentiation 
respectively. Only two of 31 cases that included both a biopsy and subsequent resection 
showed inverted growth pattern in both (Figure 1D). A summary of the types of divergent 
morphology over different grades and stages in biopsies and resections is provided in Table 6. 
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 Among the 181 consultation UTUC cases reviewed, 33 cases displayed variant 
morphology. The most common variant types of these were squamous differentiation and 
sarcomatoid (9 cases, 4.8%, each), followed by inverted growth pattern (7 cases, 3.7%) and 
glandular differentiation (6 cases, 3.2%). Less common patterns were plasmacytoid (3 cases, 
1.6%), small cell (2 cases, 1.1%), and trophoblastic (1 case, 0.5%). A mixture of variant 
patterns was seen in four cases. Each contained squamous differentiation and another 
component: sarcomatoid, glandular differentiation, or the combination of glandular 
differentiation and sarcomatoid (chondroid heterologous component). Of the sarcomatoid 
type cases, one contained osteoclast-like giant cells and another was composed of almost 
entirely rhabdoid cells. One case with squamous differentiation also contained abundant 
myxoid stroma. None of the consultation cases displaying variant morphology included both 
a biopsy and subsequent resection for comparison. A comparison of variant patterns from in-
house and consultation cases is provided in Table 5. 
1.4 
Discussion 
The frequency of variant morphology in UTUC has previously been reported as being 
between 12.0% and 24.2% in a limited number of large resection series [6, 7, 15]. The 
incidence in the renal pelvis has been reported to be as high as 40% in the literature [4, 5]. 
However, our findings are that the frequency of variant morphology is nearer to the low end 
of the percentage range reported. It is possible that the reporting studies represent cohorts of 
patients not just from hospital and community practices, but also including unique 
consultations, thus leading to a higher percentage of variant morphology. It is also likely that 
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cases sent by general pathologists for expert consultation have a greater incidence of 
morphological variants because of their diagnostically challenging nature.  
To investigate this source of bias we excluded all the consultation cases from 
statistical analyses and report consultation data separately from our in-house patients. To our 
knowledge, this study is one of the largest series examining variant UTUC patterns. In our 
opinion, the results of our in-house group provide an accurate incidence of this entity in 
general practice.  
The spectrum of variant morphologies of UTUC is similar to that from the urinary 
bladder [1]. Previous reports from resection specimens have included examples of UC with 
squamous differentiation, UC with glandular differentiation, microcystic UC, micropapillary 
UC, UC with inverted growth pattern, UC with choriocarcinoma or syncytiotrophoblastic 
giant cells (now termed UC with trophoblastic differentiation [9]), sarcomatoid UC 
(including cases with heterologous components present such as rhabdoid cells or 
chondrosarcoma [9]), lymphoepithelioma-like UC, nested UC, plasmacytoid UC, signet ring 
cell (now included in plasmacytoid UC if no extracellular mucin component is present [9]), 
small cell carcinoma, clear cell UC, and lipid-rich UC, osteoclast-rich poorly undifferentiated 
carcinoma, and UC with pseudosarcomatous stromal changes [4-6, 16-35]. In our study, the 
most frequent type from in-house resections was squamous differentiation, as in a previously 
reported series [6]. The frequency of squamous differentiation has been reported to range 
from 9.9%–18%, but our study showed a lower frequency of squamous differentiation (4.5%), 
squamous differentiation combined with sarcomatoid (0.3%), and squamous differentiation 
combined with glandular differentiation (0.3%) patterns [3, 4, 6]. One possible explanation 
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for this variation in squamous differentiation recognition could be the use of varying criteria 
by different pathologists. 
The presence of variant morphology in resection specimens (in-house cases) showed 
a significant correlation with high grade and high pT stage. In the urinary tract, variant 
differentiation frequently corresponds with higher grade and stage of urothelial cancer [9]. 
Sakano et al. reported that UTUC with variant histology was significantly associated with 
advanced pathological T stage (pT≥3), higher tumor grade (G3), and more frequent 
lymphovascular invasion [7]. On univariable analysis, variant histology was associated with 
disease recurrence and cancer specific mortality; however, multivariate analysis did not show 
an association with cancer specific mortality [6, 7]. In our study, it is not possible to 
determine an association between prognosis and variant morphology because the follow-up 
time (mean 8 months) was too short for practical analysis. Variant morphology in resections 
also showed a significant correlation with the non-papillary configuration. Rink et al. also 
reported a similar correlation. Remzi et al. reported that pT2 and higher stage tumors tend to 
have the non-papillary pattern [30]. Tumor architecture has also been reported as an 
independent predictor of cancer recurrence and cancer-specific mortality [24, 30]. Therefore, 
it is important to pay attention to the configuration of UTUC cases to detect variant 
morphology and for accurate prognostication. 
 We assessed the frequency of variant morphologies of UTUC in biopsies and 
compared it to resections. The frequency in in-house biopsies was 7.2%, about a one-half of 
that found in in-house resections. Moreover, unlike in resections, variant morphology in a 
biopsy had no association with configuration, grade, or pT stage. The most likely explanation 
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is the smaller sample size and superficial nature of these specimens precluded thorough 
assessment. This is supported by our observations that grade and morphologic patterns are 
more accurately assessed in resection specimens as compared to biopsy material. In a larger 
study, it was documented that in the urinary bladder, out of 589 transurethral biopsies of UC, 
115 cases (19.5%) demonstrated variant histologic differentiation [31]. Unlike these urinary 
bladder biopsies, upper urinary tract biopsies seem to have a lower detection rate of variant 
morphology and it is important to consider this when making management decisions. The fact 
that upper urinary tract biopsies are typically much smaller than bladder biopsies most likely 
contributes to this. Additionally, it might be difficult to distinguish cases of primary UC from 
metastasis, or direct invasion from another malignancy, on the basis of biopsy alone when 
findings demonstrate a variant morphology.  
In this study, 31 patients had a biopsy followed by surgical resection (in-house). Two 
patients (6.5%) displayed variant morphology on the preoperative biopsy. One showed low-
grade papillary UC with inverted growth pattern on biopsy. The final postoperative diagnosis 
was high-grade papillary UC with inverted growth pattern, and the stage was pT2pN2. The 
other showed high-grade papillary UC with inverted growth pattern both on biopsy and 
resection. This emphasizes that biopsy may provide limited information regarding grade and 
the extent of tumor. 
In summary, our study shows that variant morphology is found in 12.6% of UTUC. 
This was more often recognized in the resections (13.2%) than in biopsies (7.2%). The 
presence of variant morphology in resections had a significant association with non-papillary 
configuration, higher grade, and high pT stage. We conclude that the incidence of variant 
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morphology is lower in the general population than previously reported, most likely due to a 
consultation bias. Lastly, biopsy specimens may provide low sensitivity information 
regarding the presence of variant morphology.  
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Figure legends 
Figure 1. A, Papillary high grade urothelial carcinoma (right) adjacent to kidney parenchyma 
(left) (H&E 40X). B, High grade urothelial carcinoma with an infiltrative pattern (upper 
right) and nodular pattern (lower left) (H&E 100X). C, Urothelial carcinoma with 
keratinizing squamous differentiation (H&E 100X). D, Urothelial carcinoma showing 
predominant inverted growth pattern (H&E 200X). E, Urothelial carcinoma with a 
sarcomatoid component (H&E 40X). F, Urothelial carcinoma with glandular differentiation 
(H&E 200X). 
Figure 2. Less commonly observed variant morphologies in upper urinary tract urothelial 
carcinoma. A, Plasmacytoid urothelial carcinoma, tumor cells with characteristic 
plasmacytoid morphology forming discohesive sheets infiltrating a fibrous stroma (H&E 
200X). B, Lymphoepithelioma-like differentiation, an abundant lymphoid infiltrate 
surrounding and obscuring urothelial tumor cells (H&E 200X). C, Urothelial carcinoma with 
abundant myxoid stroma, single and groups of cells floating in mucin (H&E 100X). D, Giant 
cell urothelial carcinoma, large pleomorphic cells with prominent giant cell morphology 
(H&E 200X). 
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Table 1. Variant morphology and clinical characteristics of in-house cases of upper urinary tract urothelial 
carcinoma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Variant morphology 
in biopsies 
n=69 (100%) 
Variant morphology 
in resections 
n =314 (100%) 
Present (%) 
  5*  (7.3) 
Absent (%) 
64  (92.7) 
Present (%) 
42*  (13.4) 
Absent (%) 
272 (86.6) 
Age     
       ≤70   4  (80) 30  (46.9) 16  (38.1) 126  (46.2) 
       >70   1  (20) 34  (53.1) 26  (61.9) 146  (53.8) 
Sex     
       M   3  (60) 38  (59.4) 27  (64.3) 171  (62.9) 
       F   2  (40) 26  (40.6) 15  (35.7) 101  (37.1) 
Surgery     
 Nephroureterectomy   30  (71.4) 172  (63.3) 
 Ureterectomy   12  (28.6) 100 (36.7) 
Chemotherapy     
       None   30  (71.4) 221  (81.5) 
       Neoadjuvant   11  (26.2)    40  (14.5) 
       Unknown      1  (2.4)    11  (4.0) 
Follow-up (month)    <1 - 139   <1 - 89 
Died from UTUC      2  (4.8)       7  (2.5) 
*From 46 patients with variant tumors, 5 were identified on biopsy and 42 on resection. 
UTUC, upper urinary tract urothelial carcinoma. 
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Table 2. Statistical analysis of variant histology versus pathologic features for in-house cases of upper urinary tract urothelial 
carcinoma 
Variant vs Grade (n=352; P=0.00844)*  Grade vs Configuration (n=345; P<0.001) 
 Grade low Grade high   Papillary Nonpapillary 
Variant absent 68/306 238/306  Low grade 69/70 1/70 
Variant present 2/46 44/46  High grade 169/275 106/275 
Variant vs pT (n=352; P=0.0515)  Grade vs LVI (n=233; P<0.001) 
 pT low pT high   LVI not identified LVI present 
Variant absent 164/306 142/306  Low grade 49/49 0/49 
Variant present 17/46 29/46  High grade 120/184 64/184 
Variant vs Configuration (n=345; P=0.0315)  pT vs Configuration (n=345; P<0.001) 
 Papillary Nonpapillary   Papillary Nonpapillary 
Variant absent 216/300 84/300  Low pT 155/175 20/175 
Variant present 22/45 23/45  High pT 83/170 87/170 
Variant vs LVI (n=352; P=0.561)  pT stage vs LVI (n=233; P<0.001) 
 LVI not 
identified 
LVI present   LVI not identified LVI present 
Variant absent 154/210 56/210  Low pT 117/117 0/117 
Variant present 15/23 8/23  High pT 52/116 64/116 
Grade vs pT (n=352; P<0.001)  Configuration vs LVI (n=233; P<0.001) 
 Low pT High pT   LVI not identified LVI present 
Low grade 68/70 2/70  Papillary 143/169 26/169 
High grade 113/282 169/282  Nonpapillary  26/64 38/64 
LVI, lymphovascular invasion; Low pT, pTa/pTis/pT1; High pT: pT2/pT3/pT4 
* One variant case overlapping and 31 biopsies overlapping 
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Table 3. Variant morphology, grade, and stage correlation for in-house biopsy specimens 
Grade (n) High grade UC (42) Low grade UC (27) 
Variant morphology (n) Present (4) Absent (38) Present (1) Absent (26) 
Configuration (n) P (2) NP (1) NA (1) P (7) NP (22) NA (9) P (1) NP (25) NA (1) 
Noninvasive 0 1 0 3 15 4 1 25 1 
Invasive 2 0 1 4 7 5 0 0 0 
Ta/Tis 0 1 0 3 15 4 1 25 1 
T1 2 0 1 3 5 4 0 0 0 
T2 0 0 0 1 2 1 0 0 0 
NA = Not assessed due to the minute size and fragmentation of the specimen 
NP = Non-papillary 
P = Papillary  
UC = Urothelial carcinoma 
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Table 4. Variant morphology, grade, and pathologic stage correlation for in-house resection 
specimens 
Grade (n) High grade UC (259) Low grade UC (55) 
Variant morphology (n) Present (40) Absent (219) Present (2) Absent (53) 
Configuration (n) P  (20) NP  (20) P (138) NP (81) P (1) NP (1) P (53) NP (0) 
Noninvasive 2 2 27 3 1 1 46 0 
Invasive 18 18 111 78 0 0 7 0 
pTa 2 0 27 0 1 1 46 0 
pTis 0 2 0 3 0 0 0 0 
pT1 5 2 44 7 0 0 5 0 
pT2 5 1 30 20 0 0 2 0 
pT3 5 7 33 36 0 0 0 0 
pT4 3 8 4 15 0 0 0 0 
pNx 
pN0 
pN1 
pN2 
pN3 
11 
4 
1 
4 
0 
11 
4 
1 
3 
1 
84 
45 
7 
2 
0 
37 
23 
9 
12 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
32 
21 
0 
0 
0 
0 
0 
0 
0 
0 
Mx 
M1 
20 
0 
20 
0 
138 
0 
80 
1 
1 
0 
1 
0 
53 
0 
0 
0 
NP = Non-papillary 
P = Papillary   
UC = Urothelial carcinoma 
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Table 5. Summary of variant morphology in-house and consultation cases 
 In-House  Consultation* 
Total Cases 383 181 
Conventional UC 337 (88%) 148 (82%) 
Variant UC 46 (12%) 33 (18%) 
     Squamous differentiation      16 (4.1%)      9 (4.8%) 
     Inverted growth pattern      9 (2.5%)      7 (3.7%) 
     Sarcomatoid**      7 (1.8%)      9 (4.8%) 
     Glandular differentiation      6 (1.6%)      6 (3.2%) 
     Micropapillary      4 (0.9%)      0 
     Plasmacytoid      2 (0.6%)      3 (1.6%) 
     Giant cell      1 (0.3%)      0 
     Lymphoepithelioma-like      1 (0.3%)      0 
     Small cell      0      2 (1.1%) 
     Trophoblastic differentiation      0      1 (0.5%) 
UTUC, upper urinary tract urothelial carcinoma; UC, urothelial 
carcinoma. 
*Several consultation cases exhibited more than one variant; therefore the 
variant types total is greater than the variant UC total. 
**Sarcomatoid variants identified included chondroid, rhabdoid, and 
spindled morphologies. 
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Table 6. Overall in-house biopsy and resection correlation with variant morphology, grade, 
and stage 
Grade (n) High grade UC (282) Low grade UC (70) 
Variant morphology (n) Present (44) Absent (238) Present (2) 
 
Absent (68) 
Configuration (n) P (21) NP (22) NA (1) P (148) NP (84) NA (6) P (1) NP (1) P (68) 
Noninvasive 3 2 0 35 4 1 1 1 61 
Invasive 18 20 1 113 80 5 0 0 7 
Ta/Tis 3 2 0 35 4 1 1 1 61 
T1 5 4 1 45 9 4 0 0 5 
T2 5 1 0 31 20 1 0 0 2 
T3 5 7 0 33 36 0 0 0 0 
T4 3 8 0 4 15 0 0 0 0 
NA = Not able to assess due to the minute size and fragmentation of the specimen 
NP = Non-papillary 
P = Papillary    
UC = Urothelial carcinoma 
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Variant morphology in upper urinary tract urothelial carcinoma: a fourteen-year case 
series of biopsy and resection specimens  
 
Highlights 
 
 Upper urinary tract urothelial carcinoma exhibits a spectrum of variant morphology. 
 Variant morphology frequency in biopsies and resections has not been reported. 
 The frequency of variant morphology is around 12% in the general population. 
 Previously reported incidences are most likely inflated due to a consultation bias. 
